Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass

Janani Arun, Niraj Jhala, Audrey J. Lazenby, Ronald Clements, Gary A. Abrams

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition that can progress to cirrhosis and hepatocellular cancer. The most progressive form of NAFLD is nonalcoholic steatohepatitis (NASH). Currently, the only method to diagnose NASH is with a liver biopsy; however. sampling error may limit diagnostic accuracy. We investigated the discordance of paired liver biopsies in individuals undergoing gastric bypass. Methods: Two liver biopsies, composite size of ≥25 mm and ≥8 portal tracts (PTs), were obtained from the left lobe in 31 subjects. Group 1 included specimens at least 15 mm in length with ≥4 PTs compared to a second biopsy of at least 10 mm and ≥4 PTs (Group 2). Results: The mean specimen size (number of PTs) for group 1 was 20.4 ± 4.2 mm (11.7 ± 5.5 PTs) and group 2 was 16.1 ± 5.3 mm (8.2 ± 4.1 PTs). Prevalence of NASH was 26% in Group 1 and 32% in Group 2. Sampling discordance was greatest for portal fibrosis (26%), followed by zone 3 fibrosis (13%) and ballooning degeneration (3%). The negative predictive values from Group 1 liver biopsies for NASH and portal fibrosis were only 83% and 67%, respectively. Conclusions: The results demonstrate that significant sampling variability exists in class 2 and 3 obese individuals undergoing screening liver biopsies for NAFLD. The degree and histopathological discordance is dependent upon zonal location and types of injury. Nevertheless, a 25-mm biopsy specimen without zone 3 cellular ballooning or fibrosis appears adequate to exclude the diagnosis of NASH.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
JournalObesity Surgery
Volume17
Issue number2
DOIs
StatePublished - Feb 1 2007

Fingerprint

Gastric Bypass
Biopsy
Liver
Fibrosis
Non-alcoholic Fatty Liver Disease
Selection Bias
Liver Neoplasms
Wounds and Injuries

Keywords

  • Bariatric surgery
  • Morbid obesity
  • NAFLD
  • Paired liver biopsy
  • Sampling variability
  • Type 2 diabetes

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. / Arun, Janani; Jhala, Niraj; Lazenby, Audrey J.; Clements, Ronald; Abrams, Gary A.

In: Obesity Surgery, Vol. 17, No. 2, 01.02.2007, p. 155-161.

Research output: Contribution to journalArticle

Arun, Janani ; Jhala, Niraj ; Lazenby, Audrey J. ; Clements, Ronald ; Abrams, Gary A. / Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. In: Obesity Surgery. 2007 ; Vol. 17, No. 2. pp. 155-161.
@article{d7778196bff04be18c859a30b873d723,
title = "Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass",
abstract = "Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition that can progress to cirrhosis and hepatocellular cancer. The most progressive form of NAFLD is nonalcoholic steatohepatitis (NASH). Currently, the only method to diagnose NASH is with a liver biopsy; however. sampling error may limit diagnostic accuracy. We investigated the discordance of paired liver biopsies in individuals undergoing gastric bypass. Methods: Two liver biopsies, composite size of ≥25 mm and ≥8 portal tracts (PTs), were obtained from the left lobe in 31 subjects. Group 1 included specimens at least 15 mm in length with ≥4 PTs compared to a second biopsy of at least 10 mm and ≥4 PTs (Group 2). Results: The mean specimen size (number of PTs) for group 1 was 20.4 ± 4.2 mm (11.7 ± 5.5 PTs) and group 2 was 16.1 ± 5.3 mm (8.2 ± 4.1 PTs). Prevalence of NASH was 26{\%} in Group 1 and 32{\%} in Group 2. Sampling discordance was greatest for portal fibrosis (26{\%}), followed by zone 3 fibrosis (13{\%}) and ballooning degeneration (3{\%}). The negative predictive values from Group 1 liver biopsies for NASH and portal fibrosis were only 83{\%} and 67{\%}, respectively. Conclusions: The results demonstrate that significant sampling variability exists in class 2 and 3 obese individuals undergoing screening liver biopsies for NAFLD. The degree and histopathological discordance is dependent upon zonal location and types of injury. Nevertheless, a 25-mm biopsy specimen without zone 3 cellular ballooning or fibrosis appears adequate to exclude the diagnosis of NASH.",
keywords = "Bariatric surgery, Morbid obesity, NAFLD, Paired liver biopsy, Sampling variability, Type 2 diabetes",
author = "Janani Arun and Niraj Jhala and Lazenby, {Audrey J.} and Ronald Clements and Abrams, {Gary A.}",
year = "2007",
month = "2",
day = "1",
doi = "10.1007/s11695-007-9041-2",
language = "English (US)",
volume = "17",
pages = "155--161",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass

AU - Arun, Janani

AU - Jhala, Niraj

AU - Lazenby, Audrey J.

AU - Clements, Ronald

AU - Abrams, Gary A.

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition that can progress to cirrhosis and hepatocellular cancer. The most progressive form of NAFLD is nonalcoholic steatohepatitis (NASH). Currently, the only method to diagnose NASH is with a liver biopsy; however. sampling error may limit diagnostic accuracy. We investigated the discordance of paired liver biopsies in individuals undergoing gastric bypass. Methods: Two liver biopsies, composite size of ≥25 mm and ≥8 portal tracts (PTs), were obtained from the left lobe in 31 subjects. Group 1 included specimens at least 15 mm in length with ≥4 PTs compared to a second biopsy of at least 10 mm and ≥4 PTs (Group 2). Results: The mean specimen size (number of PTs) for group 1 was 20.4 ± 4.2 mm (11.7 ± 5.5 PTs) and group 2 was 16.1 ± 5.3 mm (8.2 ± 4.1 PTs). Prevalence of NASH was 26% in Group 1 and 32% in Group 2. Sampling discordance was greatest for portal fibrosis (26%), followed by zone 3 fibrosis (13%) and ballooning degeneration (3%). The negative predictive values from Group 1 liver biopsies for NASH and portal fibrosis were only 83% and 67%, respectively. Conclusions: The results demonstrate that significant sampling variability exists in class 2 and 3 obese individuals undergoing screening liver biopsies for NAFLD. The degree and histopathological discordance is dependent upon zonal location and types of injury. Nevertheless, a 25-mm biopsy specimen without zone 3 cellular ballooning or fibrosis appears adequate to exclude the diagnosis of NASH.

AB - Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic condition that can progress to cirrhosis and hepatocellular cancer. The most progressive form of NAFLD is nonalcoholic steatohepatitis (NASH). Currently, the only method to diagnose NASH is with a liver biopsy; however. sampling error may limit diagnostic accuracy. We investigated the discordance of paired liver biopsies in individuals undergoing gastric bypass. Methods: Two liver biopsies, composite size of ≥25 mm and ≥8 portal tracts (PTs), were obtained from the left lobe in 31 subjects. Group 1 included specimens at least 15 mm in length with ≥4 PTs compared to a second biopsy of at least 10 mm and ≥4 PTs (Group 2). Results: The mean specimen size (number of PTs) for group 1 was 20.4 ± 4.2 mm (11.7 ± 5.5 PTs) and group 2 was 16.1 ± 5.3 mm (8.2 ± 4.1 PTs). Prevalence of NASH was 26% in Group 1 and 32% in Group 2. Sampling discordance was greatest for portal fibrosis (26%), followed by zone 3 fibrosis (13%) and ballooning degeneration (3%). The negative predictive values from Group 1 liver biopsies for NASH and portal fibrosis were only 83% and 67%, respectively. Conclusions: The results demonstrate that significant sampling variability exists in class 2 and 3 obese individuals undergoing screening liver biopsies for NAFLD. The degree and histopathological discordance is dependent upon zonal location and types of injury. Nevertheless, a 25-mm biopsy specimen without zone 3 cellular ballooning or fibrosis appears adequate to exclude the diagnosis of NASH.

KW - Bariatric surgery

KW - Morbid obesity

KW - NAFLD

KW - Paired liver biopsy

KW - Sampling variability

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=34249852704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249852704&partnerID=8YFLogxK

U2 - 10.1007/s11695-007-9041-2

DO - 10.1007/s11695-007-9041-2

M3 - Article

C2 - 17476865

AN - SCOPUS:34249852704

VL - 17

SP - 155

EP - 161

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 2

ER -